COMMUNIQUÉS West-GlobeNewswire

-
InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to its Board of Directors
25/11/2024 -
AVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference
25/11/2024 -
Barinthus Bio Promotes SNAP-TI Co-inventor, Geoffrey Lynn, M.D., Ph.D. to Chief Scientific Officer
25/11/2024 -
Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option
25/11/2024 -
Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference
25/11/2024 -
3Daughters Wins 2024 Eddies Award from the Massachusetts Innovation Network for Game-Changing IUD (Intrauterine Device) for Contraception
25/11/2024 -
Wellthy Announces Strategic Collaboration with Benefitfocus to Expand Benefits Solutions for Employee Caregivers and Their Families
25/11/2024 -
WAKE RADIOLOGY’S DR. RAJ B. GONDALIA NAMED TO INAUGURAL RADIOLOGY BUSINESS 40 UNDER 40 LIST
25/11/2024 -
FOXO TECHNOLOGIES INC., CONFIRMS DETAILS OF SPECIAL MEETING OF SHAREHOLDERS ON NOVEMBER 29, 2024.
25/11/2024 -
Genmab to Present at Citi’s Global Healthcare Conference
25/11/2024 -
Instinct EMR Goes Live at The Schwarzman Animal Medical Center in New York City, Setting New Standards in Veterinary Medicine
25/11/2024 -
Novo Nordisk A/S - share repurchase programme
25/11/2024 -
Kratom Black Friday Sale: 30% off on All Strains | Limited Time Offer
25/11/2024 -
Alignment Health Plan Expands Access to Care in Arizona through Enhanced Agreement with Arizona Priority Care
25/11/2024 -
Derm-Biome Pharmaceuticals adds Dr. Jerry Tan, internationally renowned expert in acne and acne scarring, to its Scientific Advisory Board
25/11/2024 -
Advantage Therapeutics Inc. Announces Formation of Klothea Bio, Inc. to Advance Research and Development of Klotho Protein for Age-Related Therapeutics
25/11/2024 -
Immix Biopharma Presents Positive NXC-201 Clinical Data at 66th American Society of Hematology (ASH) Annual Meeting in 16 Relapsed/Refractory AL Amyloidosis Patients
25/11/2024 -
Cannara Biotech Inc. annonce ses résultats pour le quatrième trimestre et l’exercice 2024 : Augmentation record des ventes et du flux de trésorerie d'exploitation, renforçant sa position de leader sur le marché canadien du cannabis
25/11/2024 -
Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis Market
25/11/2024
Pages